These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22856874)

  • 1. Editorial: oncolytic viruses.
    Jia W
    Curr Pharm Biotechnol; 2012 Jul; 13(9):1731. PubMed ID: 22856874
    [No Abstract]   [Full Text] [Related]  

  • 2. Oncolytic viruses as platform for multimodal cancer therapeutics: a promising land.
    Guo ZS; Bartlett DL
    Cancer Gene Ther; 2014 Jul; 21(7):261-3. PubMed ID: 25034971
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical development of oncolytic viruses in China.
    Liang M
    Curr Pharm Biotechnol; 2012 Jul; 13(9):1852-7. PubMed ID: 21740357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent clinical experience with oncolytic viruses.
    Donnelly OG; Errington-Mais F; Prestwich R; Harrington K; Pandha H; Vile R; Melcher AA
    Curr Pharm Biotechnol; 2012 Jul; 13(9):1834-41. PubMed ID: 21740364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial overview: Oncolytic viruses--replicating virus therapeutics for the treatment of cancer.
    Bell JC; McFadden G
    Curr Opin Virol; 2015 Aug; 13():viii-ix. PubMed ID: 26260227
    [No Abstract]   [Full Text] [Related]  

  • 6. Personalizing oncolytic virotherapy?
    Kaur B; Chiocca EA
    Mol Ther; 2007 Jan; 15(1):6-7. PubMed ID: 17164767
    [No Abstract]   [Full Text] [Related]  

  • 7. Oncolytic viruses in the treatment of cancer: a review of current strategies.
    Zeyaullah M; Patro M; Ahmad I; Ibraheem K; Sultan P; Nehal M; Ali A
    Pathol Oncol Res; 2012 Oct; 18(4):771-81. PubMed ID: 22714538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncolytic viruses in cancer therapy.
    Vähä-Koskela MJ; Heikkilä JE; Hinkkanen AE
    Cancer Lett; 2007 Sep; 254(2):178-216. PubMed ID: 17383089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is oncolytic virotherapy?
    Cockle JV; Scott KJ
    Arch Dis Child Educ Pract Ed; 2018 Feb; 103(1):43-45. PubMed ID: 28588023
    [No Abstract]   [Full Text] [Related]  

  • 10. Virotherapy--cancer targeted pharmacology.
    Tedcastle A; Cawood R; Di Y; Fisher KD; Seymour LW
    Drug Discov Today; 2012 Mar; 17(5-6):215-20. PubMed ID: 22198165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncolytic HSV-1 virotherapy: clinical experience and opportunities for progress.
    Kaur B; Chiocca EA; Cripe TP
    Curr Pharm Biotechnol; 2012 Jul; 13(9):1842-51. PubMed ID: 21740359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The fourth front against cancer. The first clinical trials to test engineered viruses that attack tumour cells have yielded promising results for future cancer therapies.
    Hunter P
    EMBO Rep; 2011 Jul; 12(8):769-71. PubMed ID: 21799527
    [No Abstract]   [Full Text] [Related]  

  • 13. Oncolytic viruses: finally delivering.
    Seymour LW; Fisher KD
    Br J Cancer; 2016 Feb; 114(4):357-61. PubMed ID: 26766734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Going viral: a review of replication-selective oncolytic adenoviruses.
    Larson C; Oronsky B; Scicinski J; Fanger GR; Stirn M; Oronsky A; Reid TR
    Oncotarget; 2015 Aug; 6(24):19976-89. PubMed ID: 26280277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential of tumour cells for delivering oncolytic viruses.
    Raykov Z; Rommelaere J
    Gene Ther; 2008 May; 15(10):704-10. PubMed ID: 18356816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Questing for an optimal, universal viral agent for oncolytic virotherapy.
    Paiva LR; Martins ML; Ferreira SC
    Phys Rev E Stat Nonlin Soft Matter Phys; 2011 Oct; 84(4 Pt 1):041918. PubMed ID: 22181186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular basis of herpesviruses as oncolytic agents.
    Menotti L; Campadelli-Fiume G; Nanni P; Lollini PL; De Giovanni C
    Curr Pharm Biotechnol; 2012 Jul; 13(9):1795-803. PubMed ID: 21740356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pro-oncogenic cell signaling machinery as a target for oncolytic viruses.
    Borrego-Diaz E; Mathew R; Hawkinson D; Esfandyari T; Liu Z; Lee PW; Farassati F
    Curr Pharm Biotechnol; 2012 Jul; 13(9):1742-9. PubMed ID: 21740363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advance in herpes simplex viruses for cancer therapy.
    Liu S; Dai M; You L; Zhao Y
    Sci China Life Sci; 2013 Apr; 56(4):298-305. PubMed ID: 23564184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ReVOLT: radiation-enhanced viral oncolytic therapy.
    Advani SJ; Mezhir JJ; Roizman B; Weichselbaum RR
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):637-46. PubMed ID: 17011442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.